SAN DIEGO, June 1, 2021 /PRNewswire/ -- Evofem Biosciences,
Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will
present at the Jefferies Virtual Healthcare Conference 2021 as
follows:
Date:
|
Friday, June 4,
2021
|
Time:
|
10:30 a.m. ET (7:30
a.m. PT)
|
Webcast:
|
https://wsw.com/webcast/jeff174/evfm/1851714
|
The presentation will be webcast live and archived for 30
days thereafter.
About Evofem Biosciences
Evofem Biosciences, Inc.,
(NASDAQ: EVFM) is developing and commercializing
innovative products to address unmet needs in women's sexual
and reproductive health, including hormone-free, woman-controlled
contraception and protection from certain sexually transmitted
infections (STIs). The Company launched its first FDA-approved
commercial product, Phexxi® (lactic acid,
citric acid and potassium bitartrate), in the United
States in September 2020. The Company is evaluating lead
product candidate EVO100 for the prevention of urogenital
Chlamydia trachomatis and Neisseria gonorrhoeae
infection in women in the ongoing Phase 3 clinical
trial, 'EVOGUARD.' For more information, please visit
evofem.com.
Phexxi® is a registered trademark of Evofem
Biosciences, Inc.
Investor Relations Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-jefferies-virtual-healthcare-conference-2021-301302444.html
SOURCE Evofem Biosciences, Inc.